XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.1
Business Combinations (Tables)
3 Months Ended
Mar. 31, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Assets Acquired and Liabilities Assumed at the Acquisition Date
The preliminary fair value of the assets acquired and liabilities assumed at the acquisition date were as follows (in millions):
Cash and cash equivalents$0.7 
Accounts receivable, net1.6 
Operating lease right-of-use-assets0.3 
Identifiable intangible assets: 
Noncompete agreement (useful life of 5 years)
0.2 
Trade name (useful life of 6 months)
0.1 
Licenses (useful lives of 10 years)
0.9 
Internal-use software (useful life of 3 years)
0.1 
Goodwill28.7 
Total assets acquired32.6 
Liabilities assumed:
Current operating lease liabilities0.1 
Accounts payable0.1 
Accrued payroll0.2 
Other current liabilities0.2 
Long-term operating lease liabilities0.2 
Total liabilities assumed0.8 
Noncontrolling interests15.9 
Net assets acquired$15.9 
Schedule of Business Acquisitions, by Acquisition
Information regarding the cash paid for the acquisition during each period presented is as follows (in millions):
Three Months Ended March 31,
20222021
Fair value of assets acquired$3.9 $— 
Goodwill28.7 — 
Fair value of liabilities assumed(0.8)— 
Fair value of noncontrolling interest owned by joint venture partner
(15.9)— 
Cash paid for acquisition$15.9 $— 
Summary of Actual and Pro Forma Results of Operations for Acquisitions
The following table summarizes the results of operations of the above mentioned acquisition from the date of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisition been January 1, 2021 (in millions):
Net Operating RevenuesNet Income Attributable to Encompass Health
Acquired entities only: Actual from acquisition date to March 31, 2022
Home Health and Hospice
$1.8 $0.2 
Combined entity: Supplemental pro forma from 01/01/2022-03/31/20221,333.6 87.5 
Combined entity: Supplemental pro forma from 01/01/2021-03/31/20211,232.7 107.5